LightOx
Phase 1/2Illuminating therapeutics & research tools. LightOx are developing new therapeutic solutions to improve patient’s function and long-term outcomes with oral cancer. We have a unique range of molecular tools for use in imaging, therapeutics and assay development.
Founded
2016
Focus
OncologyDrug Delivery
About
Illuminating therapeutics & research tools. LightOx are developing new therapeutic solutions to improve patient’s function and long-term outcomes with oral cancer. We have a unique range of molecular tools for use in imaging, therapeutics and assay development.
Funding History
3Total raised: $7.5M
Series A$5.2MMaven Capital PartnersJun 15, 2021
Grant$800KInnovate UKJun 15, 2019
Seed$1.5MNorth East Venture FundJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationNewcastle, United Kingdom
StagePhase 1/2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile